Last reviewed · How we verify
NCT07020845
Artificial Intelligence, and E-Health Literacy in Fibromyalgia
trial testing Observation only in Fibromyalgia Syndrome in 212 participants. Completed in 30 May 2025.
30 May 2025
Quick facts
| Lead sponsor | Gulseren Demir Karakilic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 212 |
| Start date | 16 December 2024 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Observation only
Conditions studied
- Fibromyalgia Syndrome — all drugs for Fibromyalgia Syndrome →
- Healthy Controls Group - Age and Sex-matched — all drugs for Healthy Controls Group - Age and Sex-matched →
Sponsor
Gulseren Demir Karakilic
Who can join
Adults 18 to 50, any sex, with Fibromyalgia Syndrome or Healthy Controls Group - Age and Sex-matched. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This cross-sectional observational study aimed to assess electronic health literacy and artificial intelligence literacy among individuals diagnosed with fibromyalgia syndrome, with particular focus on artificial intelligence literacy. Although general health literacy has been investigated in this patient population, digital and artificial intelligence-related competencies have not been sufficiently studied. The research included 106 individuals diagnosed with fibromyalgia syndrome and 106 age- and sex-matched healthy volunteers, recruited between December 2024 and May 2025. All participants completed a series of standardized questionnaires, including the Revised Fibromyalgia Impact Questionnaire, the Beck Depression Inventory, the Beck Anxiety Inventory, the Electronic Health Literacy Scale, and the Artificial Intelligence Literacy Scale. The study explored demographic, clinical, and psychological factors associated with digital and artificial intelligence literacy levels among both patient and control groups.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Higher artificial intelligence literacy among patients with fibromyalgia syndrome: Results from a cross-sectional survey study.
Karakılıç GD, Balbaloğlu Ö, Göçer Ş. · · 2026 · PMID 41932771 · DOI 10.1016/j.reumae.2026.502098
Verify or expand the search:
- PubMed search for NCT07020845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation only
Trials testing the same drug.
- NCT06799624 — Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr · not yet recruiting
- NCT05976113 — A Retrospective Study on Multiple Classifier Endometrial Cancer · unknown
- NCT05852327 — Risk Stratifying COPD Exacerbations · unknown
- NCT06830915 — Evaluation of Current Practice of Antimicrobial Use and Clinical Outcome in the Management of Pneumonia Among Pediatric · completed
- NCT05255705 — Barts Revascularisation Registry · recruiting
Other recruiting trials for Fibromyalgia Syndrome
Currently open trials in the same condition.
- NCT07327775 — Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder · recruiting
- NCT06929598 — Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents · NA · recruiting
- NCT06957873 — Craniovertebral Angle and Fibromyalgia Severity · recruiting
- NCT06539793 — Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome · NA · recruiting
- NCT05900466 — Metformin for Fibromyalgia Symptoms (INFORM Trial) · Phase 2 · recruiting
Other Gulseren Demir Karakilic trials
Trials by the same sponsor.
- NCT07292181 — Central Sensitization and Neuropathic Pain in Cervicogenic Headache · completed
- NCT07292155 — Type D Personality, and Stigma in Myofascial Pain Syndrome · completed
- NCT07292129 — Smartphone Addiction in Cervicogenic Headache · completed
- NCT07292103 — Trauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders · completed
- NCT07292064 — Type D Personality, Somatization and Perceived Social Support in Temporomandibular Joint Disorders · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07020845 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulseren Demir Karakilic
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07020845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing